FreshKote gets EU approval

Aqueous Pharma has received European Union approval for its three layered artificial tear formula for dry eye, FreshKote.

Aqueous Pharma has received European Union approval for its three layered artificial tear formula for dry eye, FreshKote.

The approval comes after the formula was granted the CE Mark. FreshKote is now approved for sale in all 25 countries of the EU and was also recently launched in the United States.

The FreshKote formula is patent pending.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.